Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus
Objective Persistent positivity for lupus anticoagulant has been associated with an increased risk of thrombosis among patients with SLE. Persistent positivity is often defined as having two positive assessments separated by more than 90 days. Our objective was to determine whether frequent repeated...
Saved in:
| Main Authors: | Laurence S Magder, Mertcan Avci |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/7/1/e000406.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a systemic lupus erythematosus cardiovascular risk equation
by: Laurence S Magder, et al.
Published: (2019-12-01) -
The impacts of gender differences on systemic lupus erythematosus and lupus nephritis
by: LI Chun-hong, et al.
Published: (2019-01-01) -
OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: N V Seredavkina, et al.
Published: (2009-12-01) -
Emergencies in systemic lupus erythematosus
by: Senem Tekeoğlu, et al.
Published: (2025-07-01) -
Systemic lupus erythematosus with chorea
by: U Saatçi, et al.
Published: (1977-01-01)